Back to User profile » Dr Yosra Al-Masri
Papers published by Dr Yosra Al-Masri:
Escalation and De-Escalation Strategies for Endocrine Therapy in Early-Stage Breast Cancer
Al-Batsh T, Abdel-Razeq N, Al-Masri Y, El-Khatib O, Sharaf B, Tamimi F, Abdel-Razeq H
Biologics: Targets and Therapy 2025, 19:97-111
Published Date: 13 March 2025
Examining the Outcomes of Palliative Oophorectomy of Ovarian Metastases in de-Novo Metastatic Colorectal Cancer and Its Association with RAS Mutation Status: Insights from a Single-Institution Perspective
Alawabdeh T, Al-Ya’goub MI, Hamo K, Almasri Y, Turfa R, Alnassarwin S, Masadeh HI, Khader R, Mubaydeen T
Cancer Management and Research 2025, 17:509-515
Published Date: 7 March 2025
Dual Anti-HER2 Therapy Vs Trastuzumab Alone with Neoadjuvant Anthracycline and Taxane in HER2-Positive Early-Stage Breast Cancer: Real-World Insights
Sharaf B, Tamimi F, Al-Abdallat H, Khater S, Salama O, Zayed A, El Khatib O, Qaddoumi A, Horani M, AL-Masri Y, Asha W, Altalla’ B, Bani Hani H, Abdel-Razeq H
Biologics: Targets and Therapy 2025, 19:59-71
Published Date: 5 March 2025
Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country
Abdel-Razeq H, Sharaf B, Khater S, Baidoun HJ, Bani Hani H, Taqash A, El Khatib O, Edaily S, Abunasser M, Tamimi F, Al-Masri YN, Al-Batsh TMW, Zayed A, Ghatasheh T, Radaideh T
ImmunoTargets and Therapy 2024, 13:501-512
Published Date: 29 September 2024